Literature DB >> 18691884

Differentially expressed genes of reprogrammed human pluripotent stem cells in breast cancer.

A Rody1, T Karn, E Ruckhaeberle, L Hanker, R Gaetje, U Holtrich, M Kaufmann.   

Abstract

Reprogramming of human somatic cells into pluripotent cell types gives insight in the pathophysiology of diseases. We analysed genes recently shown to be differentially expressed in induced pluripotent stem cells (iPS) in 95 breast cancer samples. This analysis reveals two breast cancer subgroups with stem cell-like features, differing in ER-status and proliferation as well as in their clinical course of disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18691884     DOI: 10.1016/j.ejca.2008.06.037

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  3 in total

1.  [Health services research in urology: basis and examples].

Authors:  G Glaeske
Journal:  Urologe A       Date:  2014-12       Impact factor: 0.639

2.  Pluripotent Conversion of Muscle Stem Cells Without Reprogramming Factors or Small Molecules.

Authors:  Bipasha Bose; Sudheer Shenoy P
Journal:  Stem Cell Rev Rep       Date:  2016-02       Impact factor: 5.739

3.  A signature for induced pluripotent stem cell-associated genes in colorectal cancer.

Authors:  Yu-Hong Liu; Ying Li; Xun-Hua Liu; Hong-Mei Sui; Yong-Xia Liu; Zheng-Quan Xiao; Ping Zheng; Lin Chen; Su Yao; Cheng Xing; Jun Zhou; Jian-Ming Li
Journal:  Med Oncol       Date:  2013-01-11       Impact factor: 3.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.